{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:15:39Z","timestamp":1794366939339,"version":"4.9.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Sailing Program","award":["21YF1437000"],"award-info":[{"award-number":["21YF1437000"]}]},{"name":"Shanghai Sailing Program","award":["22YF1435100"],"award-info":[{"award-number":["22YF1435100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303434"],"award-info":[{"award-number":["82303434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-025-00667-2","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T03:55:34Z","timestamp":1751601334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8\/NF-\u03baB signaling pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaodong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiewen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"2","key":"667_CR1","doi-asserted-by":"publisher","first-page":"e233460","DOI":"10.1148\/radiol.233460","volume":"312","author":"PH Kuo","year":"2024","unstructured":"Kuo PH, Morris MJ, Hesterman J, Kendi AT, Rahbar K, Wei XX, Fang B, Adra N, Garje R, Michalski JM, et al. Quantitative 68Ga-PSMA-11 PET and clinical outcomes in metastatic Castration-resistant prostate Cancer following 177Lu-PSMA-617 (VISION Trial). Radiology. 2024;312(2):e233460.","journal-title":"Radiology"},{"issue":"3","key":"667_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"667_CR3","unstructured":"Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology 2020, 77(4):508\u2013547."},{"key":"667_CR4","doi-asserted-by":"crossref","unstructured":"Wang H, Li N, Liu Q, Guo J, Pan Q, Cheng B, Xu J, Dong B, Yang G, Yang B et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell 2023, 41(7).","DOI":"10.1016\/j.ccell.2023.05.016"},{"issue":"3","key":"667_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al. A framework for advancing our Understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"667_CR6","doi-asserted-by":"crossref","unstructured":"Zhang Z, Karthaus WR, Lee YS, Gao VR, Wu C, Russo JW, Liu M, Mota JM, Abida W, Linton E et al. Tumor Microenvironment-Derived NRG1 promotes antiandrogen resistance in prostate Cancer. Cancer Cell 2020, 38(2).","DOI":"10.1016\/j.ccell.2020.06.005"},{"issue":"9","key":"667_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/jcp.24546","volume":"229","author":"H Adisetiyo","year":"2014","unstructured":"Adisetiyo H, Liang M, Liao C-P, Jeong JH, Cohen MB, Roy-Burman P, Frenkel B. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. J Cell Physiol. 2014;229(9):1170\u20136.","journal-title":"J Cell Physiol"},{"issue":"1","key":"667_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13046-020-01761-1","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao J, Ding M, Su Y, Cui D, Jiang C, Zhao S, Jia G, Wang X, Ruan Y, et al. Loss of Exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis. J Experimental Clin Cancer Research: CR. 2020;39(1):282.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"7659","key":"667_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503.","journal-title":"Nature"},{"issue":"1","key":"667_CR10","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41467-020-15747-2","volume":"11","author":"BH Sung","year":"2020","unstructured":"Sung BH, von Lersner A, Guerrero J, Krystofiak ES, Inman D, Pelletier R, Zijlstra A, Ponik SM, Weaver AM. A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat Commun. 2020;11(1):2092.","journal-title":"Nat Commun"},{"key":"667_CR11","doi-asserted-by":"crossref","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 2019, 21(1).","DOI":"10.1038\/s41556-018-0250-9"},{"issue":"1","key":"667_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, Zhang Q, Lin D, Ge S, Bai M, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"issue":"1","key":"667_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-022-01359-4","volume":"15","author":"T Liu","year":"2022","unstructured":"Liu T, Han C, Fang P, Ma Z, Wang X, Chen H, Wang S, Meng F, Wang C, Zhang E, et al. Cancer-associated fibroblast-specific LncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. J Hematol Oncol. 2022;15(1):141.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"667_CR14","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, Liang Y, Zhang N, Yang Q. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11(8):3932\u201347.","journal-title":"Theranostics"},{"issue":"10","key":"667_CR15","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","volume":"83","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, Shen L, Li M, Sun J, Hao J, Li J, Zhu Z, Ge S, Zhang D, Guo H, et al. Cancer-Associated Fibroblast-Derived miR-146a-5p generates a niche that promotes bladder Cancer stemness and chemoresistance. Cancer Res. 2023;83(10):1611\u201327.","journal-title":"Cancer Res"},{"key":"667_CR16","doi-asserted-by":"crossref","unstructured":"de Keizer ROB, Vriends ALM, H\u00f6tte GJ, Paridaens DA, Wiemer EAC, Verdijk RM. miR-196b-5p and miR-107 expression differentiates ocular sebaceous carcinoma from squamous cell carcinoma of the conjunctiva. Int J Mol Sci 2022, 23(9).","DOI":"10.3390\/ijms23094877"},{"issue":"8","key":"667_CR17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jbmr.4834","volume":"38","author":"Y Xie","year":"2023","unstructured":"Xie Y, Zhou J, Tian L, Dong Y, Yuan H, Zhu E, Li X, Wang B. miR-196b-5p regulates osteoblast and osteoclast differentiation and bone homeostasis by targeting SEMA3A. J Bone Mineral Research: Official J Am Soc Bone Mineral Res. 2023;38(8):1175\u201391.","journal-title":"J Bone Mineral Research: Official J Am Soc Bone Mineral Res"},{"issue":"9","key":"667_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41419-020-02997-7","volume":"11","author":"X Huang","year":"2020","unstructured":"Huang X, Xiao S, Zhu X, Yu Y, Cao M, Zhang X, Li S, Zhu W, Wu F, Zheng X, et al. miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling. Cell Death Dis. 2020;11(9):785.","journal-title":"Cell Death Dis"},{"issue":"7","key":"667_CR19","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1096\/fj.201901562RR","volume":"34","author":"Y Shi","year":"2020","unstructured":"Shi Y, Li F, Wang S, Wang C, Xie Y, Zhou J, Li X, Wang B. miR-196b-5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF-\u03b2 signaling. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2020;34(7):9207\u201322.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"8","key":"667_CR20","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1073\/pnas.1917531117","volume":"117","author":"G Liang","year":"2020","unstructured":"Liang G, Meng W, Huang X, Zhu W, Yin C, Wang C, Fassan M, Yu Y, Kudo M, Xiao S, et al. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer. Proc Natl Acad Sci USA. 2020;117(8):4347\u201357.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"667_CR21","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.7150\/jca.84460","volume":"14","author":"C-Y Tsai","year":"2023","unstructured":"Tsai C-Y, Liao J-B, Lee Y-C, Yang Y-F. HOXC8 mediates osteopontin expression in gastric cancer cells. J Cancer. 2023;14(13):2552\u201361.","journal-title":"J Cancer"},{"issue":"11","key":"667_CR22","doi-asserted-by":"publisher","first-page":"e21346","DOI":"10.1016\/j.heliyon.2023.e21346","volume":"9","author":"S Wu","year":"2023","unstructured":"Wu S, Zhu D, Feng H, Li Y, Zhou J, Li Y, Hou T. Comprehensive analysis of HOXC8 associated with tumor microenvironment characteristics in colorectal cancer. Heliyon. 2023;9(11):e21346.","journal-title":"Heliyon"},{"key":"667_CR23","doi-asserted-by":"publisher","first-page":"793678","DOI":"10.3389\/fonc.2021.793678","volume":"11","author":"H Gu","year":"2021","unstructured":"Gu H, Zhong Y, Liu J, Shen Q, Wei R, Zhu H, Zhang X, Xia X, Yao M, Ni M. The role of miR-4256\/HOXC8 signaling Axis in the gastric Cancer progression: evidence from lncRNA-miRNA-mRNA network analysis. Front Oncol. 2021;11:793678.","journal-title":"Front Oncol"},{"issue":"1","key":"667_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-017-0605-z","volume":"16","author":"M Shah","year":"2017","unstructured":"Shah M, Cardenas R, Wang B, Persson J, Mongan NP, Grabowska A, Allegrucci C. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. Mol Cancer. 2017;16(1):38.","journal-title":"Mol Cancer"},{"issue":"11","key":"667_CR25","first-page":"1700","volume":"124","author":"X-H Wang","year":"2011","unstructured":"Wang X-H, Zhao F-J, Han B-M, Jiang Q, Wang Y-C, Wu J-H, Tang Y-Q, Zhang Y-P, Xia S-J. Primary stromal cells isolated from human various histological\/pathological prostate have different phenotypes and tumor promotion role. Chin Med J. 2011;124(11):1700\u20137.","journal-title":"Chin Med J"},{"issue":"4","key":"667_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng.3523","volume":"48","author":"T Whitington","year":"2016","unstructured":"Whitington T, Gao P, Song W, Ross-Adams H, Lamb AD, Yang Y, Svezia I, Klevebring D, Mills IG, Karlsson R, et al. Gene regulatory mechanisms underpinning prostate cancer susceptibility. Nat Genet. 2016;48(4):387\u201397.","journal-title":"Nat Genet"},{"issue":"21","key":"667_CR27","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1158\/1078-0432.CCR-14-1566","volume":"21","author":"B-D Wang","year":"2015","unstructured":"Wang B-D, Ceniccola K, Yang Q, Andrawis R, Patel V, Ji Y, Rhim J, Olender J, Popratiloff A, Latham P, et al. Identification and functional validation of reciprocal microRNA-mRNA pairings in African American prostate Cancer disparities. Clin Cancer Research: Official J Am Association Cancer Res. 2015;21(21):4970\u201384.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"3","key":"667_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BVSK, Varambally S, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22(3):298\u2013305.","journal-title":"Nat Med"},{"issue":"18","key":"667_CR29","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 1990;87(18):7235\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"667_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","volume":"8","author":"C Han","year":"2020","unstructured":"Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res. 2020;8(1):64.","journal-title":"Biomark Res"},{"issue":"1","key":"667_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, Yin R. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12(1):86.","journal-title":"J Hematol Oncol"},{"issue":"14","key":"667_CR32","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R. FAP promotes immunosuppression by Cancer-Associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124\u201335.","journal-title":"Cancer Res"},{"issue":"2","key":"667_CR33","doi-asserted-by":"publisher","first-page":"188450","DOI":"10.1016\/j.bbcan.2020.188450","volume":"1874","author":"P Pai","year":"2020","unstructured":"Pai P, Sukumar S. HOX genes and the NF-\u03baB pathway: A convergence of developmental biology, inflammation and cancer biology. Biochim Et Biophys Acta Reviews Cancer. 2020;1874(2):188450.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"issue":"3","key":"667_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1042\/BJ20121651","volume":"451","author":"S Strickson","year":"2013","unstructured":"Strickson S, Campbell DG, Emmerich CH, Knebel A, Plater L, Ritorto MS, Shpiro N, Cohen P. The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system. Biochem J. 2013;451(3):427\u201337.","journal-title":"Biochem J"},{"issue":"5659","key":"667_CR35","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1090922","volume":"303","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Sci (New York NY). 2004;303(5659):848\u201351.","journal-title":"Sci (New York NY)"},{"issue":"4","key":"667_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4161\/cbt.6.4.4255","volume":"6","author":"A Orimo","year":"2007","unstructured":"Orimo A, Weinberg RA. Heterogeneity of stromal fibroblasts in tumor. Cancer Biol Ther. 2007;6(4):618\u20139.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"667_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI117736","volume":"95","author":"L R\u00f8nnov-Jessen","year":"1995","unstructured":"R\u00f8nnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Investig. 1995;95(2):859\u201373.","journal-title":"J Clin Investig"},{"issue":"13","key":"667_CR38","doi-asserted-by":"publisher","first-page":"11379","DOI":"10.1007\/s00432-023-05011-7","volume":"149","author":"T Li","year":"2023","unstructured":"Li T, Zhou Z, Xie Z, Fan X, Zhang Y, Zhang Y, Song X, Ruan Y. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing. J Cancer Res Clin Oncol. 2023;149(13):11379\u201395.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"667_CR39","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","volume":"41","author":"H Wang","year":"2023","unstructured":"Wang H, Li N, Liu Q, Guo J, Pan Q, Cheng B, Xu J, Dong B, Yang G, Yang B, et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell. 2023;41(7):1345\u2013e13621349.","journal-title":"Cancer Cell"},{"issue":"9","key":"667_CR40","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med. 2012;18(9):1359\u201368.","journal-title":"Nat Med"},{"key":"667_CR41","doi-asserted-by":"crossref","unstructured":"Bonollo F, Thalmann GN, Kruithof-de Julio M, Karkampouna S. The role of Cancer-Associated fibroblasts in prostate Cancer tumorigenesis. Cancers (Basel) 2020, 12(7).","DOI":"10.3390\/cancers12071887"},{"issue":"9","key":"667_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"667_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12935-024-03305-5","volume":"24","author":"Z Gao","year":"2024","unstructured":"Gao Z, Zhang N, An B, Li D, Fang Z, Xu D. Comprehensive analyses of the cancer-associated fibroblast subtypes and their score system for prediction of outcomes and immunosuppressive microenvironment in prostate cancer. Cancer Cell Int. 2024;24(1):127.","journal-title":"Cancer Cell Int"},{"key":"667_CR44","doi-asserted-by":"publisher","first-page":"1412337","DOI":"10.3389\/fcell.2024.1412337","volume":"12","author":"H Chen","year":"2024","unstructured":"Chen H, Fang S, Zhu X, Liu H. Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression. Front Cell Dev Biol. 2024;12:1412337.","journal-title":"Front Cell Dev Biol"},{"key":"667_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-018-0587-8","volume":"11","author":"W Si","year":"2019","unstructured":"Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of MicroRNAs in cancer drug resistance. Clin Epigenetics. 2019;11:1\u201324.","journal-title":"Clin Epigenetics"},{"key":"667_CR46","doi-asserted-by":"crossref","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci. 2002;99(24):15524\u20139.","DOI":"10.1073\/pnas.242606799"},{"issue":"3","key":"667_CR47","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/pharmaceutics13030380","volume":"13","author":"N Arrighetti","year":"2021","unstructured":"Arrighetti N, Beretta GL. MiRNAs as therapeutic tools and biomarkers for prostate cancer. Pharmaceutics. 2021;13(3):380.","journal-title":"Pharmaceutics"},{"issue":"1","key":"667_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","volume":"67","author":"X Huang","year":"2015","unstructured":"Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol. 2015;67(1):33\u201341.","journal-title":"Eur Urol"},{"issue":"10","key":"667_CR49","doi-asserted-by":"publisher","first-page":"e12136","DOI":"10.1002\/jev2.12136","volume":"10","author":"ES Martens-Uzunova","year":"2021","unstructured":"Martens-Uzunova ES, Kusuma GD, Crucitta S, Lim HK, Cooper C, Riches JE, Azad A, Ochiya T, Boyle GM, Southey MC. Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer. J Extracell Vesicles. 2021;10(10):e12136.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"667_CR50","doi-asserted-by":"publisher","first-page":"14055","DOI":"10.1002\/jcb.28680","volume":"120","author":"W Chen","year":"2019","unstructured":"Chen W, Yao G, Zhou K. miR-103a\u20102\u20105p\/miR\u201030c\u20101\u20103p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7. J Cell Biochem. 2019;120(8):14055\u201364.","journal-title":"J Cell Biochem"},{"issue":"28","key":"667_CR51","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1038\/s41388-019-0823-5","volume":"38","author":"CE Fletcher","year":"2019","unstructured":"Fletcher CE, Sulpice E, Combe S, Shibakawa A, Leach DA, Hamilton MP, Chrysostomou SL, Sharp A, Welti J, Yuan W. Androgen receptor-modulatory MicroRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. 2019;38(28):5700\u201324.","journal-title":"Oncogene"},{"issue":"1","key":"667_CR52","first-page":"247","volume":"16","author":"H Li","year":"2018","unstructured":"Li H, Feng C, Shi S. miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6. Oncol Lett. 2018;16(1):247\u201352.","journal-title":"Oncol Lett"},{"issue":"2","key":"667_CR53","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2018.05.052","volume":"501","author":"X Zhao","year":"2018","unstructured":"Zhao X, Zhang W, Ji W. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2. Biochem Biophys Res Commun. 2018;501(2):584\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"667_CR54","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1476-4598-13-218","volume":"13","author":"Y-C Lu","year":"2014","unstructured":"Lu Y-C, Chang JT, Liao C-T, Kang C-J, Huang S-F, Chen IH, Huang C-C, Huang Y-C, Chen W-H, Tsai C-Y, et al. OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 2014;13:218.","journal-title":"Mol Cancer"},{"issue":"7","key":"667_CR55","doi-asserted-by":"publisher","first-page":"e67846","DOI":"10.1371\/journal.pone.0067846","volume":"8","author":"C How","year":"2013","unstructured":"How C, Hui ABY, Alajez NM, Shi W, Boutros PC, Clarke BA, Yan R, Pintilie M, Fyles A, Hedley DW, et al. MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PLoS ONE. 2013;8(7):e67846.","journal-title":"PLoS ONE"},{"issue":"7","key":"667_CR56","doi-asserted-by":"publisher","first-page":"e68442","DOI":"10.1371\/journal.pone.0068442","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu Y, Zheng W, Song Y, Ma W, Yin H. Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis. PLoS ONE. 2013;8(7):e68442.","journal-title":"PLoS ONE"},{"key":"667_CR57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/1471-2407-12-348","volume":"12","author":"X-h Liu","year":"2012","unstructured":"Liu X-h, Lu K-h, Wang K-m, Sun M, Zhang E-b, Yang J-s, Yin D-d, Liu Z-l, Zhou J, Liu Z-, et al. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer. 2012;12:348.","journal-title":"BMC Cancer"},{"issue":"11\u201312","key":"667_CR58","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1387\/ijdb.180330rr","volume":"62","author":"R Krumlauf","year":"2018","unstructured":"Krumlauf R. Hox genes, clusters and collinearity. Int J Dev Biol. 2018;62(11\u201312):659\u201363.","journal-title":"Int J Dev Biol"},{"issue":"42","key":"667_CR59","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1038\/onc.2016.95","volume":"35","author":"WW Teo","year":"2016","unstructured":"Teo WW, Merino VF, Cho S, Korangath P, Liang X, Wu R, Neumann NM, Ewald AJ, Sukumar S. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35(42):5539\u201351.","journal-title":"Oncogene"},{"issue":"14","key":"667_CR60","first-page":"2910","volume":"115","author":"C Bach","year":"2010","unstructured":"Bach C, Buhl S, Mueller D, Garc\u00eda-Cu\u00e9llar M-P, Maethner E, Slany RK. Leukemogenic transformation by HOXA cluster genes. Blood J Am Soc Hematol. 2010;115(14):2910\u20138.","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"667_CR61","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/onc.2015.174","volume":"35","author":"CT Collins","year":"2016","unstructured":"Collins CT, Hess JL. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets. Oncogene. 2016;35(9):1090\u20138.","journal-title":"Oncogene"},{"issue":"24","key":"667_CR62","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.1305172110","volume":"110","author":"M Sun","year":"2013","unstructured":"Sun M, Song C-X, Huang H, Frankenberger CA, Sankarasharma D, Gomes S, Chen P, Chen J, Chada KK, He C. HMGA2\/TET1\/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci. 2013;110(24):9920\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"667_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccr.2013.06.003","volume":"24","author":"MC Mulero","year":"2013","unstructured":"Mulero MC, Ferres-Marco D, Islam A, Margalef P, Pecoraro M, Toll A, Drechsel N, Charneco C, Davis S, Bellora N. Chromatin-bound I\u03baB\u03b1 regulates a subset of polycomb target genes in differentiation and cancer. Cancer Cell. 2013;24(2):151\u201366.","journal-title":"Cancer Cell"},{"issue":"2","key":"667_CR64","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.atherosclerosis.2007.04.055","volume":"195","author":"CM Trivedi","year":"2007","unstructured":"Trivedi CM, Patel RC, Patel CV. Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis. 2007;195(2):e50\u201360.","journal-title":"Atherosclerosis"},{"issue":"12","key":"667_CR65","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/S0006-2952(99)00234-8","volume":"58","author":"A Chariot","year":"1999","unstructured":"Chariot A, Gielen J, Merville M-P, Bours V. The homeodomain-containing proteins: an update on their interacting partners. Biochem Pharmacol. 1999;58(12):1851\u20137.","journal-title":"Biochem Pharmacol"},{"issue":"37","key":"667_CR66","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1038\/onc.2013.404","volume":"33","author":"Y Kim","year":"2014","unstructured":"Kim Y, Kim I, Kang T, Choi C, Kim K, Kim M, Nam K, Jung C. HOXB13 downregulates intracellular zinc and increases NF-\u03baB signaling to promote prostate cancer metastasis. Oncogene. 2014;33(37):4558\u201367.","journal-title":"Oncogene"},{"issue":"47","key":"667_CR67","doi-asserted-by":"publisher","first-page":"46541","DOI":"10.1074\/jbc.M306381200","volume":"278","author":"P Viatour","year":"2003","unstructured":"Viatour P, Legrand-Poels S, Van Lint C, Warnier M, Merville M-P, Gielen J, Piette J, Bours V, Chariot A. Cytoplasmic I\u03baB\u03b1 increases NF-\u03baB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J Biol Chem. 2003;278(47):46541\u20138.","journal-title":"J Biol Chem"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-025-00667-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:03:51Z","timestamp":1751605431000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-025-00667-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1186\/s13062-025-00667-2","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}